# Ascentage Pharma Group International: Form 6-K, filed May 28, 2026

- Company: [Ascentage Pharma Group International](/companies/aapg.md) (CIK 2023311)
- Form: 6-K
- Filed: 2026-05-28
- Accepted by EDGAR: May 28, 2026, 08:29 ET
- Period: 2026-05-27
- Accession: 0001213900-26-061791
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2023311/000121390026061791/ea0292326-6k_ascentage.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2023311/000121390026061791/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2023311/000121390026061791/ea0292326-6k_ascentage.htm

Filed May 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-061791. Last ingested by Listed: Nov 5, 2026, 12:38 ET. No prices; not investment advice.